Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Psychopharmacology (Berl). 2011 May 28;218(3):579–587. doi: 10.1007/s00213-011-2343-z

Scheme 1.

Scheme 1

Imaging study timeline. Top boxes reflect the intravenous doses of cariprazine administered ~15 min prior to PET measurement 2 or PET measurement 3. The boxes below reflect the series of PET measurements per study day. The information below the series of PET measurements refers to timing in minutes of the blood samples for estimation of the plasma concentration of cariprazine, desmethyl-, and didesmethyl-cariprazine